Literature DB >> 11156789

Hyperintense signal abnormality in subarachnoid spaces and basal cisterns on MR images of children anesthetized with propofol: new fluid-attenuated inversion recovery finding.

C G Filippi1, A M Ulug, D Lin, L A Heier, R D Zimmerman.   

Abstract

BACKGROUND AND
PURPOSE: MR imaging is the method of choice for pediatric neuroimaging. Sedation is often needed to suppress patient motion and ensure diagnostic image quality, and propofol is rapidly becoming the preferred anesthetic. The purpose of this study was to document a new finding on fast fluid-attenuated inversion recovery (fast-FLAIR) MR images of children anesthetized with propofol that can be mistaken for subarachnoid space pathologic abnormality.
METHODS: A retrospective analysis was conducted of 55 MR images of the brain for children who ranged in age from 1 week to 12 years. Forty-two patients received chloral hydrate, and 13 received propofol anesthetic. Multiplanar MR images were studied to detect the presence or absence of hyperintense signal (artifact) in the subarachnoid spaces and basal cisterns. The T1 values and null times of chloral hydrate, propofol, and CSF were determined in vitro at room temperature by using an inversion recovery pulse sequence at 1.5 T.
RESULTS: The fast-FLAIR images of all 13 patients who received propofol had hyperintense signal abnormality. For 10 (77%) of 13 patients, this artifact was in the basal cisterns and subarachnoid spaces overlying the brain convexity. For three (23%) of 13 patients, this artifact was in the convexity region only. Two patients underwent follow-up MR imaging with a nonpropofol anesthetic agent, and the artifact resolved. None of the images of the children who received chloral hydrate had this artifact. The T1 value of chloral hydrate was 0.2 s, of propofol was 1.86 s, and of CSF was 2.32 s at room temperature.
CONCLUSION: The fast-FLAIR images of children anesthetized with propofol have artifactual hyperintense signal in the basal cisterns and subarachnoid spaces, and this artifact mimics disease of the subarachnoid space. The T1 value of propofol approaches that of CSF. Depending on the chosen null time, there may be incomplete nulling of signal coming from propofol. To account for this observation, other possible causes include increased CSF pulsation in children creating motion artifact, changes in arterial oxygen concentration intrinsic to propofol or related to the supplemental oxygen normally administered, or changes in CSF protein levels related to propofol binding to proteins for uptake into CSF.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11156789      PMCID: PMC7973951     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  25 in total

1.  Use of fluid attenuated inversion recovery (FLAIR) pulse sequences in MRI of the brain.

Authors:  J V Hajnal; D J Bryant; L Kasuboski; P M Pattany; B De Coene; P D Lewis; J M Pennock; A Oatridge; I R Young; G M Bydder
Journal:  J Comput Assist Tomogr       Date:  1992 Nov-Dec       Impact factor: 1.826

2.  Total intravenous anesthesia with propofol in pediatric patients outside the operating room.

Authors:  L D Martin; L R Pasternak; M A Pudimat
Journal:  Anesth Analg       Date:  1992-04       Impact factor: 5.108

3.  Truncation artifacts in magnetic resonance imaging.

Authors:  M L Wood; R M Henkelman
Journal:  Magn Reson Med       Date:  1985-12       Impact factor: 4.668

4.  Fast fluid-attenuated inversion-recovery MR of intracranial infections.

Authors:  K Tsuchiya; S Inaoka; Y Mizutani; J Hachiya
Journal:  AJNR Am J Neuroradiol       Date:  1997-05       Impact factor: 3.825

5.  The influence of anesthetic choice, PaCO2, and other factors on osmotic blood-brain barrier disruption in rats with brain tumor xenografts.

Authors:  L G Remsen; M A Pagel; C I McCormick; S A Fiamengo; G Sexton; E A Neuwelt
Journal:  Anesth Analg       Date:  1999-03       Impact factor: 5.108

6.  Why fat is bright in RARE and fast spin-echo imaging.

Authors:  R M Henkelman; P A Hardy; J E Bishop; C S Poon; D B Plewes
Journal:  J Magn Reson Imaging       Date:  1992 Sep-Oct       Impact factor: 4.813

7.  EPI imaging of global increase of brain MR signal with breath-hold preceded by breathing O2.

Authors:  K K Kwong; I Wanke; K M Donahue; T L Davis; B R Rosen
Journal:  Magn Reson Med       Date:  1995-03       Impact factor: 4.668

8.  Suspected multiple sclerosis: MR imaging with a thin-section fast FLAIR pulse sequence.

Authors:  R H Hashemi; W G Bradley; D Y Chen; J E Jordan; J A Queralt; A E Cheng; J N Henrie
Journal:  Radiology       Date:  1995-08       Impact factor: 11.105

9.  Light anaesthesia with propofol for paediatric MRI.

Authors:  M Vangerven; J Van Hemelrijck; P Wouters; E Vandermeersch; H Van Aken
Journal:  Anaesthesia       Date:  1992-08       Impact factor: 6.955

Review 10.  Pharmacokinetic implications for the clinical use of propofol.

Authors:  J Kanto; E Gepts
Journal:  Clin Pharmacokinet       Date:  1989-11       Impact factor: 6.447

View more
  14 in total

1.  Noninvasive MR cisternography with fluid-attenuated inversion recovery and 100% supplemental O(2) in the evaluation of neurocysticercosis.

Authors:  Flávio Braga; Antônio J Rocha; Hélio R Gomes; Guinel Hernandez Filho; Carlos J Silva; Ricardo B Fonseca
Journal:  AJNR Am J Neuroradiol       Date:  2004-02       Impact factor: 3.825

2.  3D fluid-attenuated inversion recovery imaging: reduced CSF artifacts and enhanced sensitivity and specificity for subarachnoid hemorrhage.

Authors:  N Lummel; V Schoepf; M Burke; H Brueckmann; J Linn
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-15       Impact factor: 3.825

3.  Reduction of Oxygen-Induced CSF Hyperintensity on FLAIR MR Images in Sedated Children: Usefulness of Magnetization-Prepared FLAIR Imaging.

Authors:  H-K Jeong; S W Oh; J Kim; S-K Lee; S J Ahn
Journal:  AJNR Am J Neuroradiol       Date:  2016-03-17       Impact factor: 3.825

4.  Paramagnetic effect of supplemental oxygen on CSF hyperintensity on fluid-attenuated inversion recovery MR images.

Authors:  Yoshimi Anzai; Makiko Ishikawa; Dennis W W Shaw; Alan Artru; Vasily Yarnykh; Kenneth R Maravilla
Journal:  AJNR Am J Neuroradiol       Date:  2004-02       Impact factor: 3.825

5.  Relationship between the concentration of supplemental oxygen and signal intensity of CSF depicted by fluid-attenuated inversion recovery imaging.

Authors:  Flávio T Braga; Antônio J da Rocha; Guinel Hernandez Filho; Renê K Arikawa; Ivone M Ribeiro; Ricardo B Fonseca
Journal:  AJNR Am J Neuroradiol       Date:  2003-10       Impact factor: 3.825

Review 6.  Isolated acute nontraumatic cortical subarachnoid hemorrhage.

Authors:  V Cuvinciuc; A Viguier; L Calviere; N Raposo; V Larrue; C Cognard; F Bonneville
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-21       Impact factor: 3.825

7.  Fluid-attenuated inversion recovery MR imaging and subarachnoid hemorrhage: not a panacea.

Authors:  Mona Mohamed; D Cressler Heasly; Banu Yagmurlu; David M Yousem; D Cressler Heasely
Journal:  AJNR Am J Neuroradiol       Date:  2004-04       Impact factor: 3.825

Review 8.  Abnormal hyperintensity within the subarachnoid space evaluated by fluid-attenuated inversion-recovery MR imaging: a spectrum of central nervous system diseases.

Authors:  Masayuki Maeda; Akira Yagishita; Tatsuya Yamamoto; Hajime Sakuma; Kan Takeda
Journal:  Eur Radiol       Date:  2003-12       Impact factor: 5.315

9.  Elevated cerebral blood volume contributes to increased FLAIR signal in the cerebral sulci of propofol-sedated children.

Authors:  J H Harreld; N D Sabin; M G Rossi; R Awwad; W E Reddick; Y Yuan; J O Glass; Q Ji; A Gajjar; Z Patay
Journal:  AJNR Am J Neuroradiol       Date:  2014-04-03       Impact factor: 3.825

10.  MR imaging features of amyloid-related imaging abnormalities.

Authors:  J Barakos; R Sperling; S Salloway; C Jack; A Gass; J B Fiebach; D Tampieri; D Melançon; Y Miaux; G Rippon; R Black; Y Lu; H R Brashear; H M Arrighi; K A Morris; M Grundman
Journal:  AJNR Am J Neuroradiol       Date:  2013-04-11       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.